Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic And Philips Collaborate On Image-Guided Ablation For Atrial Fibrillation

Executive Summary

Medtronic will co-promote Philips' Kodex-EPD dielectric imaging and navigation system with features to support atrial fibrillation ablation procedures.

You may also be interested in...

J&J, Acutus And Boston Scientific Announce Plans For Pulsed Field AF-Ablation Technologies

Pulsed field ablation, which uses a controlled electrical field instead of focused heat or cold, has shown promise as a safer alternative to thermal and cryo approaches for atrial fibrillation ablation.

ESC Congress 2018 Wrap-Up: Medtronic's Arctic Front; B. Braun's SeQuent Please; Biotronik's Orsiro Stent

Almost 33,000 cardiology professionals attended the 2018 European Society of Cardiology Congress last week in Munich. The meeting included 4,500 abstracts, including 17 late-breaking clinical trials, six clinical trial updates, and 20 registries. Here are some of the highlights of interest to the medtech industry.

Philips, Medtronic Seek To Navigate Lung Cancer Patients Toward Better Care

The two medtech leaders announced a partnership to develop and commercialize the LungGPS patient management platform, originally developed by superDimension and acquired by Medtronic in the Coviden merger. The patient and data management platform helps track and manage patients diagnosed with lung nodules, from identifying the nodules on images, through diagnosis, treatment, and long-term survivorship.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts